Dear Friends and Colleagues,
I am pleased to share with you Jhpiego’s Annual Report for 2012. Throughout its 40-year history, Jhpiego has been an organization looking forward, toward the next country in need, the next global health challenge, the next great innovation that will save lives. But it’s also important for us to reflect upon our accomplishments as an organization so we may gain valuable perspective on what has worked and why. This year marks my 10th anniversary at Jhpiego and, even after a decade, I’m still amazed by the incredible impact of our programs and the selfless dedication of our employees in preventing the needless deaths of women and their families.
Over the past year, Jhpiego has seen unprecedented growth and success in regions of the world and health intervention areas that we could only have dreamt of a few short years ago. This is due in large part to support from our partners and the innovative spirit and “can do” attitude of our incredible staff, who work in collaboration with our partners on the ground to make these dreams a reality.
For example, Jhpiego, with support from the Bill & Melinda Gates Foundation and others, has implemented the first postpartum intrauterine contraceptive device (IUCD) national scale-up effort in the world. Currently in 19 states in India, the program has trained more than 4,200 providers, as of December 2012, and counseled more than 1.5 million women.
Across the Indian Ocean in Tanzania, a Jhpiego-led, U.S. Agency for International Development-funded and government-supported project to prevent the transmission of HIV reached an incredible milestone this year, providing voluntary medical male circumcision services to its 100,000th client. Used in combination with other HIV prevention measures, this underutilized intervention is making a real difference in stopping the spread of this epidemic.
USAID’s Maternal and Child Health Integrated Program, which is led by Jhpiego, has shown tremendous growth in four years (2009–2012), reaching more than 1.8 million women with services to help them give birth safely. This year also marked the first live webcast of a high-level MCHIP technical meeting. Jhpiego has made significant progress in fighting malaria through one of our many successful public-private partnerships. With support from the Jubilee Joint Venture in Ghana, malaria prevention services are being integrated with reproductive health, family planning and immunization to strengthen health services for nearly 1 million residents in the western region.
Developing the next generation of extremely low-cost innovations remained a top strategic priority. Three global health projects designed by Jhpiego and partners were again among the top winners at the prestigious Saving Lives at Birth: A Grand Challenge for Development competition.
Looking ahead, Jhpiego will focus its efforts on shining an even brighter spotlight on cervical cancer, a preventable disease that kills 270,000 women each year. Our highly successful single visit approach (SVA) to screening and treatment saves lives and must be available for every woman in need.
On behalf of Jhpiego and the vulnerable women and families we serve, I would like to express our deep-felt appreciation to all of our partners, donors, colleagues and friends who have made the past year such a resounding success. We look forward to working with you in the many years to come.
Leslie Mancuso, PhD, RN, FAAN
President and Chief Executive Officer